Menu
/REGISTER
PPB
Montecito
ROAM
Loading...
You are here:  Home  >  Latest news  >  Current Article

Amgen approves $5 billion stock repurchase

By   /   Monday, December 7th, 2009  /   Comments Off on Amgen approves $5 billion stock repurchase

    Print       Email

Thousand Oaks-based biotech firm Amgen said Dec. 7 that its board of directors has authorized the firm to buy back as much as $5 billion in stock.

Amgen has $1.2 billion of potential stock repurchases under its previous buyback program. Companies often buy back stock to boost share prices or earnings per share.

Amgen’s shares slipped half a percent to $56.55 on the news. The shares are roughly where they stood a year ago, despite peaking near $65 in late summer.

Are you a subscriber? If not, sign up today for a four-week FREE trial or subscribe and receive the 2009 Book of Lists free with your purchase.

    Print       Email

You might also like...

Lompoc medical center may acquire Sansum’s Lompoc clinic

Read More →